Dunvegan Associates, Inc.: CLX position timeline
Available 13F reports, 13D and 13G stakes and each Form 3, 4 and 5 line of Dunvegan Associates, Inc. on CLX, newest first. How the timeline and the estimate are built.
Dunvegan Associates, Inc. held 3,857 CLX shares at 2015-12-31 per its 13F-HR filed 2017-04-28.
the latest 13F is the newest step
- period ended2015-12-3113F 3,857 sharesChange vs previous 13F -123 shares
0.57% of the 13F portfolio, value $489,000.
13F-HR 0001214659-17-002793 filed by Dunvegan Associates, Inc.
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).
- period ended2015-09-3013F 3,980 sharesChange vs previous 13F -160 shares
0.52% of the 13F portfolio, value $460,000.
13F-HR 0001214659-17-002791 filed by Dunvegan Associates, Inc.
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).
- period ended2015-06-3013F 4,140 sharesChange vs previous 13F 0 shares
0.48% of the 13F portfolio, value $431,000.
13F-HR 0001214659-17-002789 filed by Dunvegan Associates, Inc.
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).
- period ended2015-03-3113F 4,140 sharesChange vs previous 13F 0 shares
0.4% of the 13F portfolio, value $457,000.
13F-HR 0001214659-17-002787 filed by Dunvegan Associates, Inc.
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).
- period ended2014-12-3113F 4,140 sharesChange vs previous 13F +130 shares
0.37% of the 13F portfolio, value $431,000.
13F-HR 0001214659-17-002783 filed by Dunvegan Associates, Inc.
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).
- period ended2014-09-3013F 4,010 sharesChange vs previous 13F 0 shares
0.35% of the 13F portfolio, value $385,000.
13F-HR 0001214659-17-002781 filed by Dunvegan Associates, Inc.
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).
- period ended2014-06-3013F 4,010 sharesChange vs previous 13F 0 shares
0.31% of the 13F portfolio, value $367,000.
13F-HR 0001214659-17-002779 filed by Dunvegan Associates, Inc.
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).
- period ended2014-03-3113F 4,010 sharesChange vs previous 13F not available
0.3% of the 13F portfolio, value $353,000.
13F-HR 0001214659-17-002777 filed by Dunvegan Associates, Inc.
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).